Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.
about
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1Survivors Remorse: antibody-mediated protection against HIV-1.Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV InfectionHIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities.Epitope target structures of Fc-mediated effector function during HIV-1 acquisition.Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivoRationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.Glycan modulation and sulfoengineering of anti-HIV-1 monoclonal antibody PG9 in plants.HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humansDual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters.Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and DenmarkA new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virusThe role of Fc receptors in HIV prevention and therapy.Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat ProteinThe HIV-1 gp120 V1V2 loop: structure, function and importance for vaccine development.Immunotherapeutic Approaches for the Control and Eradication of HIV.HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies.Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infectionLack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients.Beyond Viral Neutralization.Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region.An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus MacaquesNon-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity.Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates.Conserved HIV Epitopes for an Effective HIV Vaccine.Patterns of conserved gp120 epitope presentation on attached HIV-1 virions.Alga-Made Anti-Hepatitis B Antibody Binds to Human Fcγ Receptors.
P2860
Q26782237-48FB6015-6816-43ED-92C8-4FAAB2D064C9Q30238730-0C4248CD-2751-45BD-BC99-E7A5D2A761EDQ30390233-9E37C954-A45C-4BDA-B41E-B54B9F8D4632Q33620546-F5630B5D-89CB-4032-8850-34FCB5E25D4BQ33900395-1CF46401-A276-4142-AB13-6AB0ED78BC90Q33924272-2EE72948-6BBE-4B12-ADEF-5E6704E29C4FQ34527478-2506D61A-0CA3-40A2-8DE1-AD7E5B1B177EQ34540352-DAAF4D98-C054-48D7-A9AF-F065FCD7DB5BQ34869927-93DD5CFB-04B8-42C9-9D4F-8D32A0291BCEQ35913921-6E165F0D-BE2B-4195-AE5D-2479A5042695Q36012177-A27CD238-50A1-47E0-B6F4-CF483F95D855Q36179265-1F6A66F4-CF3C-4141-BE01-4EE666F321FDQ36252656-BFE83105-8EA8-4844-AB51-C6097E2854E3Q36266486-569EFE2B-456C-44C6-8DFA-79AEB8A76A25Q36479067-2C6391D6-ED71-4A48-98B7-6AB52C8FFCFCQ36837324-93AA4C3A-2260-4ECF-B307-B2DDC8CA95BAQ36906910-B76D5B59-DD17-494D-89DB-41959DFA8396Q37072545-FAF71E5E-D080-4E2F-835E-54B4D6D0D402Q37113972-D5CC9994-382A-45E8-8AF5-372443DE7485Q37402557-E4C6AF8D-26A5-42EE-9D4F-6D51CFE2C1C7Q37409262-04C37090-F06C-49D1-B451-FEB1A924F894Q37512871-C94C7771-95A4-4056-804A-D9A88CCF9B37Q37592654-CCDDE241-BE24-4D6D-B7C7-3E7DD272BD59Q38243948-5EAE8640-2FB2-41AD-B9B4-257A0C0053FEQ38635401-6D26E728-DF4C-427B-8FC5-0306E39843B2Q38897259-EA561B2F-D412-432F-928B-41EDAEEF5F2AQ38977425-45872354-EF1A-4175-84C8-3F4DB72C5A2CQ38998925-5B469B5A-8014-4D78-9EF0-56DC6B03603CQ39108760-1014C529-DD4C-44EC-BF6C-2CA51E6F85D2Q39189458-DE8BD688-7D6A-4FD6-913D-00760759F062Q40052007-D8122090-8EB1-4E88-96D7-7E00E623B0BCQ40286085-91D9DE7A-2FC0-4394-9B6F-39B98A02614CQ40373085-C5614964-5C1B-414B-BBA1-2939414639AFQ40730039-918E4C18-3192-406F-8C64-AFE279828528Q40748041-C8E33697-0A19-4A2B-B9BB-98CF07C10B60Q41924059-BF2AA59C-5D21-4BA9-9991-F37AB08B062AQ42368984-BACC8BA6-2452-4093-BB85-129F82E21268Q47093684-FDE143E7-1951-455E-BDC1-B9C3418CE32DQ47109778-664DA5FD-A969-4FAE-97E9-FB1BA1ADF570Q47341896-A78263AF-73DC-4E03-B51C-7EEFC299D0B6
P2860
Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@en
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@nl
type
label
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@en
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@nl
prefLabel
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@en
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@nl
P2093
P2860
P921
P1433
P1476
Epitope specificity of human i ...... cytotoxicity [ADCC] responses.
@en
P2093
Justin Pollara
M Anthony Moody
Marzena Pazgier
Mattia Bonsignori
P2860
P304
P356
10.2174/1570162X113116660059
P5008
P577
2013-07-01T00:00:00Z